Skip to main content
BAX
NYSE Industrial Applications And Services

Baxter Upsizes Debt Tender to $600M and Loosens Leverage Covenant

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$25.88
Mkt Cap
$13.411B
52W Low
$15.73
52W High
$30
52W Position info
65% above low
Off High info
14% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BAX sits 65% above its 52-week low of $15.73.

Summary

Baxter upsized its debt tender offer to $600 million and loosened its net leverage covenant, reflecting active balance sheet management amid high leverage.


Key Events · Financing and Capital Events · BAX

  • Tender Offer Upsized to $600M

    Baxter increased the aggregate purchase price cap for its cash tender offers from $500 million to $600 million, exercising a previously disclosed right to amend the terms.

  • Pricing and Acceptance Details

    Total Consideration per $1,000 principal amount ranges from $587.34 for 3.132% Notes due 2051 to $867.59 for 2.539% Notes due 2032. The 2.539% Notes due 2032 will be prorated at approximately 31.37%.

  • Credit Agreement Amendment

    Amendment No. 2 raises the maximum net leverage ratio to 4.25x for fiscal quarters ending September 30, 2026 through June 30, 2027, then steps down to 4.00x for September 30, 2027 and 3.75x thereafter.

  • Borrower Removal

    Baxter World Trade SRL was removed as a Borrower under the Amended Credit Agreement, simplifying the borrowing structure.


Analysis · BAX · Industrial Applications And Services

Baxter increased its cash tender offer cap from $500 million to $600 million and announced pricing for the repurchase of four series of senior notes. The company also amended its credit agreement to raise the maximum net leverage ratio to 4.25x through mid-2027, providing additional financial flexibility. The tender offers are part of a broader debt management strategy following strong Q2 results, but the covenant amendment signals elevated leverage levels that the company is proactively addressing.

At the time of this filing, BAX was trading at $25.88 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.4B. The 52-week trading range was $15.73 to $30.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BAX - Latest Insights

BAX
Aug 04, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
7
BAX
Jul 30, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
7
BAX
Jul 30, 2026, 11:33 AM EDT
Source: Benzinga
Importance Score:
8
BAX
Jul 30, 2026, 7:26 AM EDT
Source: Reuters
Importance Score:
8
BAX
Jul 30, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7